Novartis AG-RegNVSEF
13F holders, Q2 2026 (June 30)2holders
0new positions
0sold out
$156.63avg. 13F price*
At the end of Q2 2026, 2 institutions reported holding Novartis AG-Reg (NVSEF) in their 13F filings, unchanged from Q1 2026. 0 opened new positions and 0 sold out. The largest holders were Partners Capital Investment Group, LLP ($3.8M) and Generali Investments CEE, investicni spolecnost, a.s. ($2.5M).
- Company
- Novartis AG-Reg
- CUSIP
- H5820Q150
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q1 2026 → Q2 2026: 5,207 shares sold, net −5,207 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Partners Capital Investment Group, LLP | 0.13% | Reduce -13.8% | 24,335 | $3.8M |
| Generali Investments CEE, investicni spolecnost, a.s. | 0.12% | Reduce -7.8% | 15,729 | $2.5M |
"% of holder's portfolio" is NVSEF's weight in each manager's 13F, not the share of Novartis AG-Reg the manager owns.